Substances & reference · openFDA

Historical FDA documents

FDA press releases and papers from the agency's history, as full text. 8,858 records; openFDA updated it 2026-09-23. About this dataset

Newest records

  • FDA NEWS RELEASE For Immediate Release: April 23, 2014

    FDA NEWS RELEASE For Immediate Release: April 23, 2014 FDA approves Sylvant for rare Castleman’s disease The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Cast…

    Press release2 pages
  • For Immediate Release: April 7, 2014

    FDA NEWS RELEASE For Immediate Release: April 7, 2014 Espafiol (Spanish) FFX(Chinese) EZFEE (Japanese) @201 (Korean) FDA warns consumers not to use Zi Xiu Tang Bee Pollen capsules Tainted product contains undeclared drug…

    Press release2 pages
  • For Immediate Release: April 16, 2014

    FDA NEWS RELEASE For Immediate Release: April 16, 2014 En Espafiol Puerto Rico bakery agrees to stop manufacturing and distributing products Los Genuinos, Inc., a Bayamon, Puerto Rico, food manufacturer, has agreed under…

    Press release2 pages
  • For Immediate Release - December 4, 2014

    FDA News Release For Immediate Release - December 4, 2014 FDA approves Jakafi to treat patients with a chronic type of bone marrow disease First FDA-approved drug for polycythemia vera The U.S. Food and Drug Administrat…

    Press release2 pages
  • For Immediate Release: Feb. 4, 2014

    FDA NEWS RELEASE For Immediate Release: Feb. 4, 2014 Espafiol FDA launches its first national public education campaign to prevent, reduce youth tobacco use The U.S. Food and Drug Administration today announced the launc…

    Press release2 pages
  • For Immediate Release -July 16, 2014

    FDA Statement For Immediate Release -July 16, 2014 Update on findings in the FDA cold storage area on the NIH campus As previously reported, on July 1, 2014, biological samples were found in the cold storage area of U.S…

    Press release1 pages
  • For Immediate Release - December 19, 2014

    FDA News Release For Immediate Release - December 19, 2014 FDA approves Lynparza to treat advanced ovarian cancer First LDT companion diagnostic test also approved to identify appropriate patients Espafiol The U.S. Food…

    Press release3 pages
  • For Immediate Release - December 12, 2014

    FDA News Release For Immediate Release - December 12, 2014 FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer The U.S. Food and Drug Administration today expanded the approved use of Cyra…

    Press release2 pages
  • FDA News Release For Immediate Release - August 11, 2014

    FDA News Release For Immediate Release - August 11, 2014 FDA approves first non-invasive DNA screening test for colorectal cancer Collaboration with CMS contributed to proposed Medicare coverage Espafiol The U.S. Food an…

    Press release3 pages
  • For Immediate Release - October 29, 2014

    FDA News Release For Immediate Release - October 29, 2014 First vaccine approved by FDA to prevent serogroup B Meningococcal disease The U.S. Food and Drug Administration announced today the approval of Trumenba, the fi…

    Press release2 pages
  • For Immediate Release - August 25, 2014

    FDA News Release For Immediate Release - August 25, 2014 FDA takes action against Georgia dietary supplement manufacturer A dietary supplement manufacturer is under a federal court order to stop illegally marketing its…

    Press release1 pages
  • For Immediate Release: May 16, 2014

    FDA NEWS RELEASE For Immediate Release: May 16, 2014 U.S. Marshals seize unapproved drugs at Ohio warehouse U.S. Marshals, at the request of the U.S. Food and Drug Administration and the U.S. Attorney for the Southern D…

    Press release2 pages
  • For Immediate Release - December 11, 2014

    FDA News Release For Immediate Release - December 11, 2014 FDA approves first test to confirm the presence of Human T-cell Lymphotropic Virus-l/Il antibodies The U.S. Food and Drug Administration today approved MP Diagn…

    Press release2 pages
  • FDA News Release For Immediate Release - December 15, 2014

    FDA News Release For Immediate Release - December 15, 2014 Espafiol FDA allows marketing of the first newborn screening test to help detect Severe Combined Immunodeficiency The U.S. Food and Drug Administration today all…

    Press release2 pages
  • For Immediate Release: April 3, 2014

    HHS NEWS RELEASE For Immediate Release: April 3, 2014 Proposed health IT strategy aims to promote innovation, protect patients, and avoid regulatory duplication HHS today released a draft report that includes a proposed…

    Press release3 pages
  • For Immediate Release: Jan. 10, 2014

    FDA NEWS RELEASE For Immediate Release: Jan. 10, 2014 En Espafiol FDA approves Mekinist in combination with Tafinlar for advanced melanoma This week the U.S. Food and Drug Administration approved Mekinist (trametinib) in…

    Press release2 pages
  • For Immediate Release - July 31, 2014

    FDA News Release For Immediate Release - July 31, 2014 FDA takes steps to help ensure the reliability of certain diagnostic tests Reinforces agency’s commitment to fostering personalized medicine Today, the U.S. Food an…

    Press release2 pages
  • For Immediate Release: Feb. 10, 2014

    FDA NEWS RELEASE For Immediate Release: Feb. 10, 2014 En Espafiol FDA warns against using Uncle Ben’s Infused Rice Mars Foodservices recalls all lot numbers of Infused Rice linked to recent illness in Texas Fast Facts 0…

    Press release3 pages
  • For Immediate Release - September 10, 2014

    FDA News Release For Immediate Release - September 10, 2014 FDA approves weight-management drug Contrave Espafiol The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydr…

    Press release3 pages
  • For Immediate Release - November 21, 2014

    FDA News Release For Immediate Release - November 21, 2014 FDA takes enforcement action against Michigan sandwich company The U.S. Food and Drug Administration, in a complaint filed by the Department ofJustice, is seeki…

    Press release1 pages
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.